2023
DOI: 10.2903/j.efsa.2023.7872
|View full text |Cite
|
Sign up to set email alerts
|

Assessment of the feed additive consisting of Pediococcus pentosaceus DSM 23376 for all animal species for the renewal of its authorisation (Agri‐King, Inc.)

Abstract: Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the assessment of the application for renewal of Pediococcus pentosaceus DSM 23376, as a technological additive to improve ensiling of forage for all animal species. The applicant has provided evidence that the additive currently on the market complies with the existing conditions of authorisation. There is no new evidence that would lead the FEEDAP Panel to reconsider its previous conclusions. Thus, the Panel c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 5 publications
(5 reference statements)
0
1
0
Order By: Relevance
“…Another opinion, released in May 2023 considering the assessment of the application for renewal of Lactiplantibacillus plantarum DSM 23375, a technological additive to improve ensiling of fresh material for all animal species was requested (EFSA FEEDAP Panel, 2023c). In this case, the applicant provided evidence, that additive is already on the market and complies existing conditions of authorisation.…”
Section: Inhibitory Activity and Main Points In Risk Assessmentmentioning
confidence: 99%
“…Another opinion, released in May 2023 considering the assessment of the application for renewal of Lactiplantibacillus plantarum DSM 23375, a technological additive to improve ensiling of fresh material for all animal species was requested (EFSA FEEDAP Panel, 2023c). In this case, the applicant provided evidence, that additive is already on the market and complies existing conditions of authorisation.…”
Section: Inhibitory Activity and Main Points In Risk Assessmentmentioning
confidence: 99%